Literature DB >> 20717489

Anxiety Disorders with Comorbid Substance Use Disorders: Diagnostic and Treatment Considerations.

Sudie E Back1, Kathleen T Brady.   

Abstract

Entities:  

Year:  2008        PMID： 20717489      PMCID： PMC2921723          DOI： 10.3928/00485713-20081101-01

Source DB:  PubMed          Journal:  Psychiatr Ann        ISSN： 0048-5713


× No keyword cloud information.
  37 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

2.  The role of childhood risk factors in initiation of alcohol use and progression to alcohol dependence.

Authors:  Carolyn E Sartor; Michael T Lynskey; Andrew C Heath; Theodore Jacob; William True
Journal:  Addiction       Date:  2007-02       Impact factor: 6.526

3.  The spectrum of substance use in mood and anxiety disorders.

Authors:  Alfredo Sbrana; Jacopo Vittoriano Bizzarri; Paola Rucci; Chiara Gonnelli; Maria Rosa Doria; Sabrina Spagnolli; Laura Ravani; Federica Raimondi; Lilliana Dell'Osso; Giovanni Battista Cassano
Journal:  Compr Psychiatry       Date:  2005 Jan-Feb       Impact factor: 3.735

4.  Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder.

Authors:  Kathleen T Brady; Susan Sonne; Raymond F Anton; Carrie L Randall; Sudie E Back; Kit Simpson
Journal:  Alcohol Clin Exp Res       Date:  2005-03       Impact factor: 3.455

5.  Treatment of social phobia with gabapentin: a placebo-controlled study.

Authors:  A C Pande; J R Davidson; J W Jefferson; C A Janney; D J Katzelnick; R H Weisler; J H Greist; S M Sutherland
Journal:  J Clin Psychopharmacol       Date:  1999-08       Impact factor: 3.153

Review 6.  Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence.

Authors:  M A Posternak; T I Mueller
Journal:  Am J Addict       Date:  2001

Review 7.  Substance use disorders in patients with posttraumatic stress disorder: a review of the literature.

Authors:  L K Jacobsen; S M Southwick; T R Kosten
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

Review 8.  The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings.

Authors:  M G Kushner; K Abrams; C Borchardt
Journal:  Clin Psychol Rev       Date:  2000-03

9.  Alcohol-dependent patients with comorbid phobic disorders: a comparison between comorbid patients, pure alcohol-dependent and pure phobic patients.

Authors:  Annemiek Schadé; Loes A Marquenie; Anton J L M Van Balkom; Maarten W J Koeter; Edwin De Beurs; Wim Van Den Brink; Richard Van Dyck
Journal:  Alcohol Alcohol       Date:  2004 May-Jun       Impact factor: 2.826

10.  A placebo-controlled trial of buspirone in anxious inpatient alcoholics.

Authors:  R Malcolm; R F Anton; C L Randall; A Johnston; K Brady; A Thevos
Journal:  Alcohol Clin Exp Res       Date:  1992-12       Impact factor: 3.455
View more
  14 in total

1.  Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample.

Authors:  Jessica F Magidson; Shang-Min Liu; C W Lejuez; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2012-03-23       Impact factor: 4.791

2.  Associations between post-traumatic stress symptoms, stimulant use, and treatment outcomes: a secondary analysis of NIDA's Women and Trauma study.

Authors:  Lesia M Ruglass; Denise A Hien; Mei-Chen Hu; Aimee N C Campbell
Journal:  Am J Addict       Date:  2013-06-26

3.  Unhealthy Alcohol Use Associated with Obsessive-Compulsive Symptoms: The Moderating Effects of Anxiety and Depression.

Authors:  Michael P Randazza; Dean McKay; Jafar Bakhshaie; Eric A Storch; Michael J Zvolensky
Journal:  J Obsessive Compuls Relat Disord       Date:  2022-02-08       Impact factor: 1.677

4.  Overexpression of the Histone Dimethyltransferase G9a in Nucleus Accumbens Shell Increases Cocaine Self-Administration, Stress-Induced Reinstatement, and Anxiety.

Authors:  Ethan M Anderson; Erin B Larson; Daniel Guzman; Anne Marie Wissman; Rachael L Neve; Eric J Nestler; David W Self
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

5.  The Relationship Between Generalized Anxiety Symptoms and Treatment Dropout Among Women in Residential Treatment for Substance Use Disorders.

Authors:  JoAnna Elmquist; Ryan C Shorey; Scott E Anderson; Gregory L Stuart
Journal:  Subst Use Misuse       Date:  2016-04-20       Impact factor: 2.164

6.  Transdiagnostic preventative intervention for subclinical anxiety: Development and initial validation.

Authors:  Kristina J Korte; Norman B Schmidt
Journal:  J Psychiatr Res       Date:  2020-05-03       Impact factor: 4.791

7.  An Examination of Comorbid Generalized Anxiety Disorder and Chronic Pain on Substance Misuse in a Canadian Population-Based Survey.

Authors:  Elena Bilevicius; Jordana L Sommer; Matthew T Keough; Renée El-Gabalawy
Journal:  Can J Psychiatry       Date:  2020-01-03       Impact factor: 4.356

8.  Knockdown of the histone di-methyltransferase G9a in nucleus accumbens shell decreases cocaine self-administration, stress-induced reinstatement, and anxiety.

Authors:  Ethan M Anderson; Haosheng Sun; Daniel Guzman; Makoto Taniguchi; Christopher W Cowan; Ian Maze; Eric J Nestler; David W Self
Journal:  Neuropsychopharmacology       Date:  2018-12-26       Impact factor: 7.853

9.  The histone methyltransferase G9a mediates stress-regulated alcohol drinking.

Authors:  Ethan M Anderson; Marcelo F Lopez; Abigail Kastner; Patrick J Mulholland; Howard C Becker; Christopher W Cowan
Journal:  Addict Biol       Date:  2021-05-19       Impact factor: 4.280

Review 10.  Potential of eye movement desensitization and reprocessing therapy in the treatment of post-traumatic stress disorder.

Authors:  Tracy M McGuire; Christopher W Lee; Peter D Drummond
Journal:  Psychol Res Behav Manag       Date:  2014-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.